Leukapheresis is used to collect T cells, a type of white blood cell, for chimeric antigen receptor (CAR) T-cell therapy. The T cells obtained by leukapheresis are genetically modified to kill cancer cells before being infused back into the patient. This process supports treatments for such cancers as B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma.
Discover